No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Cosmos Holdings CEO Makes Bold Stock Purchase!
SoFi Offers Access to New Class of Cosmos Fund
Cosmos Health 2024 Rev $54.4M
Press Release: Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
COSMOS Pharmaceutical Reports Strong Financial Growth for Nine-Month Period
COSMOS Pharmaceutical Sees FY Net Y24.50B